JPS62258313A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPS62258313A JPS62258313A JP10284286A JP10284286A JPS62258313A JP S62258313 A JPS62258313 A JP S62258313A JP 10284286 A JP10284286 A JP 10284286A JP 10284286 A JP10284286 A JP 10284286A JP S62258313 A JPS62258313 A JP S62258313A
- Authority
- JP
- Japan
- Prior art keywords
- thiamine
- dna
- ester
- skin
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 43
- 235000019157 thiamine Nutrition 0.000 claims abstract description 40
- 239000011721 thiamine Substances 0.000 claims abstract description 33
- 229960003495 thiamine Drugs 0.000 claims abstract description 23
- -1 thiamine ester Chemical class 0.000 claims abstract description 16
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000020955 thiamine monophosphate Nutrition 0.000 claims abstract description 6
- 239000011621 thiamine monophosphate Substances 0.000 claims abstract description 6
- 229960002363 thiamine pyrophosphate Drugs 0.000 claims abstract description 6
- 235000008170 thiamine pyrophosphate Nutrition 0.000 claims abstract description 6
- 239000011678 thiamine pyrophosphate Substances 0.000 claims abstract description 6
- 239000006210 lotion Substances 0.000 abstract description 9
- 208000000453 Skin Neoplasms Diseases 0.000 abstract description 6
- 201000000849 skin cancer Diseases 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 5
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 abstract description 4
- GUGWNSHJDUEHNJ-UHFFFAOYSA-N thiamine(1+) monophosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N GUGWNSHJDUEHNJ-UHFFFAOYSA-N 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 229930003231 vitamin Natural products 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 239000011782 vitamin Substances 0.000 abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 3
- 229930003451 Vitamin B1 Natural products 0.000 abstract description 2
- 238000004925 denaturation Methods 0.000 abstract description 2
- 230000036425 denaturation Effects 0.000 abstract description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 abstract description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 2
- 235000010374 vitamin B1 Nutrition 0.000 abstract description 2
- 239000011691 vitamin B1 Substances 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- HZSAJDVWZRBGIF-UHFFFAOYSA-N thiamine(1+) monophosphate(1-) Chemical compound CC1=C(CCOP(O)([O-])=O)SC=[N+]1CC1=CN=C(C)N=C1N HZSAJDVWZRBGIF-UHFFFAOYSA-N 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 29
- 239000006071 cream Substances 0.000 description 14
- 238000009472 formulation Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 9
- 150000003544 thiamines Chemical class 0.000 description 8
- PHNDUXLWAVSUAL-SHYZEUOFSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidenepyrimidin-2-one Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 PHNDUXLWAVSUAL-SHYZEUOFSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 206010042496 Sunburn Diseases 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 208000038016 acute inflammation Diseases 0.000 description 4
- 230000006022 acute inflammation Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 150000004005 nitrosamines Chemical class 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- ZLOIGESWDJYCTF-UHFFFAOYSA-N 4-Thiouridine Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-UHFFFAOYSA-N 0.000 description 3
- ZLOIGESWDJYCTF-XVFCMESISA-N 4-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=S)C=C1 ZLOIGESWDJYCTF-XVFCMESISA-N 0.000 description 3
- 231100000277 DNA damage Toxicity 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 108091093078 Pyrimidine dimer Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000005783 single-strand break Effects 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- 230000005778 DNA damage Effects 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000000886 photobiology Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- WBNQDOYYEUMPFS-UHFFFAOYSA-N N-nitrosodiethylamine Chemical compound CCN(CC)N=O WBNQDOYYEUMPFS-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- ASJWEHCPLGMOJE-LJMGSBPFSA-N ac1l3rvh Chemical compound N1C(=O)NC(=O)[C@@]2(C)[C@@]3(C)C(=O)NC(=O)N[C@H]3[C@H]21 ASJWEHCPLGMOJE-LJMGSBPFSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000001909 effect on DNA Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000007598 thiamine phosphates Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、壬アミンおよび/またはチアミンエステルを
含有し2日焼は止め化粧品1日焼は用化粧品などに利用
され得る化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a cosmetic containing amine and/or thiamin ester and which can be used in sun protection cosmetics, sun protection cosmetics, and the like.
(従来の技術)
太陽光による日焼けは280〜400nmの紫外線が原
因であることが知られている。日焼けは二つのタイプに
分類される。一つは、主として、280〜320nmの
紫外線(A領域紫外線)によって引き起こされる皮膚の
紅斑や痛みを伴う急性の炎症であり、もう一つは、主と
して、320〜400nmの紫外線(B領域紫外線もし
くは近紫外線)によって引き起こされるメラニン色素の
沈着による皮膚の黒化である。皮膚の炎症を引き起こす
ことなく美しい小麦色の肌に日焼けするという目的で2
日焼は用化粧品がすでに製造され販売されている。例え
ば、パラアミノ安息香酸エチル、シノキサート(商品名
)、オキシベンゾン(商品名)などを紫外線吸収剤とし
て配合した化粧料(例えば、クリーム、乳液などの基礎
化粧品:ファンデーション。(Prior Art) It is known that sunburn caused by sunlight is caused by ultraviolet rays of 280 to 400 nm. Sunburn is classified into two types. One is acute inflammation accompanied by skin erythema and pain caused mainly by ultraviolet rays in the range 280 to 320 nm (UV rays in the A range), and the other is acute inflammation that is mainly caused by ultraviolet rays in the range 320 to 400 nm (UV rays in the B range or near range). It is a darkening of the skin due to the deposition of melanin pigment caused by ultraviolet rays. 2 for the purpose of tanning the skin to a beautiful tan color without causing skin irritation.
Cosmetics for sun tanning are already manufactured and sold. For example, cosmetics containing ethyl para-aminobenzoate, cinoxate (trade name), oxybenzone (trade name), etc. as UV absorbers (for example, basic cosmetics such as creams and emulsions: foundations).
プレストパウダーなどの仕上げ用化粧品)がある。Finishing cosmetics such as pressed powder) are available.
使用される紫外線吸収剤は、280〜320nmの紫外
線をよく吸収し、かつ近紫外線を透過する。そのため、
皮膚の急性炎症を引き起こすことなく所望の度合に皮膚
を黒くすることが可能であるが、透過した近紫外線が皮
膚細胞のDNAに損傷を与えることが最近の研究で明ら
かになってきた。例えば。The ultraviolet absorber used absorbs ultraviolet rays of 280 to 320 nm well and transmits near ultraviolet rays. Therefore,
Although it is possible to darken the skin to the desired degree without causing acute inflammation of the skin, recent studies have revealed that the transmitted near ultraviolet light damages the DNA of skin cells. for example.
紫外線、特に近紫外線の照射により、 DNA鎖中にチ
ミンニ量体が生じることが報告されている。最近では、
化粧品分野で使用されているSPF値で日焼けの程度を
判断する代わりに、このチミンニ量体を機器で定量した
値で判断する試みもなされている。チミンニ量体を有す
るDNAが直接生体に悪影客を及ぼすことは知られてい
ないが、このように紫外線、特に近紫外線、の照射によ
り皮膚細胞中のDNAの一部に変性が生じるという事実
は、太陽光の強さと皮膚のじみやしわ、さらに皮膚ガン
発生とが相関性を有することを示唆すると考えられる。It has been reported that thymine dimers are generated in DNA strands by irradiation with ultraviolet light, especially near ultraviolet light. recently,
Instead of determining the degree of sunburn by the SPF value used in the cosmetics field, attempts have been made to determine the degree of sunburn by measuring the thymine dimer using a device. Although it is not known that DNA containing thymine dimers directly causes negative effects on living organisms, the fact that irradiation with ultraviolet rays, especially near ultraviolet rays, causes denaturation of a portion of DNA in skin cells. This is thought to suggest that there is a correlation between the intensity of sunlight and skin blemishes and wrinkles, as well as the occurrence of skin cancer.
このような考えをもとに太陽光、特に近紫外線。Based on this idea, sunlight, especially near ultraviolet rays.
とDNAとの関係が研究され5例えば、ピーク(Pea
k)らは細胞中に3通常、存在する物質である4−チオ
ウリジンまたは4−チオデオキシウリジンの存在下で近
紫外線を照射すると、 DNAの一本鎖切断が引き起こ
されることを報告している。(J、 G。For example, the relationship between Pea and DNA has been studied5.
reported that irradiation with near ultraviolet light in the presence of 4-thiouridine or 4-thiodeoxyuridine, which are substances normally present in cells, causes single-strand breaks in DNA. (J, G.
Peak et al、 (1984) ;フォトケミ
ストリー アンド フォトバイオロジー(Photoc
hemistry andPhotobiology)
、 39.713 ) 、近紫外線自体はDNAに吸
収されないことを考えあわせると、近紫外線によるDN
Aの損傷は、上記4−チオウリジンや4−チオデオキシ
ウリジンのように近紫外線を吸収しうる物質が近紫外線
を吸収する結果、何らかの変化を受け、これがDNAに
対して影響を与えると考えられる。特に、細胞中の酸素
含有化合物の酸素原子が近紫外線によって励起され、こ
れがDNA損傷に関与すると考えられている。Peak et al. (1984); Photochemistry and Photobiology (Photoc
hemistry and photobiology)
, 39.713), taking into account that near ultraviolet rays themselves are not absorbed by DNA, it is assumed that near ultraviolet rays do not absorb DNA.
It is thought that the damage in A occurs as a result of a substance capable of absorbing near ultraviolet rays, such as 4-thiouridine and 4-thiodeoxyuridine, absorbing near ultraviolet rays and undergoes some kind of change, which affects the DNA. In particular, oxygen atoms in oxygen-containing compounds in cells are excited by near ultraviolet light, and this is thought to be involved in DNA damage.
上記4−チオウリジンや4−チオデオキシウリジンのよ
うに細胞中に存在する物質以外にも環境に広く存在する
物質が近紫外線照射を受けて変化し、これが細胞中のD
NAの損傷を引き起こすことも考えられる。例えば、空
気中にppbのオーダーで存在するニトロソアミン類、
あるいは化粧品中のアミン類が酸化を受けて生じる微量
のニトロソアミン類がDNAに影響を与えることが考え
られる。In addition to substances that exist in cells, such as the above-mentioned 4-thiouridine and 4-thiodeoxyuridine, substances that are widely present in the environment change when exposed to near ultraviolet irradiation, and this changes the D
It is also possible that it causes damage to NA. For example, nitrosamines, which exist in the air in ppb order,
Alternatively, trace amounts of nitrosamines produced when amines in cosmetics undergo oxidation may affect DNA.
ニトロソアミン類は1本来、 DNAの反応性を持たな
いが近紫外線照射を受けて変化すると、これがDNAの
一本鎖切断を引き起こしたり、 DNAのアミノ酸配列
を変えるなどして生体細胞に突然変異を引き起こすこと
が知られている。Nitrosamines do not originally have DNA reactivity, but when they change when exposed to near-UV irradiation, they cause mutations in living cells by causing single-strand breaks in DNA or changing the amino acid sequence of DNA. It is known.
このように、近紫外線は1間接的にDNAを損傷・変性
させ皮膚のしみやしわ、ひいては皮膚癌の原因となる。In this way, near ultraviolet rays indirectly damage and denature DNA, causing spots and wrinkles on the skin, and eventually skin cancer.
現在使用されている日焼は用化粧品は。What are the tanning cosmetics currently in use?
皮膚の急性的な炎症を防ぐことはできるが、近紫外線の
吸収によるDNAの損傷に対しては全く効果がない。Although it can prevent acute skin inflammation, it has no effect on DNA damage caused by absorption of near ultraviolet rays.
(発明が解決しようとする問題点) 本発明は上記従来の欠点を解決するものであり。(Problem that the invention attempts to solve) The present invention solves the above-mentioned conventional drawbacks.
その目的とするところは9日焼は止め化粧品5日焼は用
化粧品などに応用され得、 DNAの損傷を抑制し、し
たがって皮膚癌を防止しうる化粧料を提供することにあ
る。The purpose is to provide cosmetics that can be applied to sunscreen cosmetics, sunburn prevention cosmetics, etc., and that can suppress DNA damage and, therefore, prevent skin cancer.
(問題点を解決するための手段および作用)本発明の化
粧料は、チアミンおよび/またはチアミンエステルを含
有し、そのことにより°上記目的が達成される。(Means and effects for solving the problems) The cosmetic of the present invention contains thiamin and/or thiamin ester, thereby achieving the above object.
本発明の化粧料に含有されるチアミンは必須ビタミンの
一種であるビタミンB、であり、植物体などに広く含有
される。チアミンエステルとしては、リン酸エステル類
、硫酸エステル類、カルボン酸エステル類などが用いら
れる。チアミンリン酸エステル類、特に生体内に存在す
るチアミンピロリン酸エステル、チアミンモノリン酸エ
ステルなどが好適に利用される。このようなチアミンお
よび/またはチアミンエステル(以下、チアミン類とい
う。)を含有する化粧料はどのような形態であってもよ
い。例えば、化粧水、クリーム、乳液などの基礎化粧品
;ファンデーション、口紅。Thiamine contained in the cosmetic of the present invention is vitamin B, which is a type of essential vitamin, and is widely contained in plants and the like. As the thiamine ester, phosphoric acid esters, sulfuric acid esters, carboxylic acid esters, etc. are used. Thiamine phosphate esters, particularly thiamine pyrophosphate ester, thiamine monophosphate ester, etc., which exist in living bodies, are suitably used. Cosmetics containing such thiamine and/or thiamine esters (hereinafter referred to as thiamines) may be in any form. For example, basic cosmetics such as lotion, cream, emulsion; foundation, lipstick.
プレストパウダーなどの仕上げ用化粧品が挙げられる。Examples include finishing cosmetics such as pressed powder.
チアミン類は水溶性であるため従来の紫外線吸収剤1例
えばパラアミノ安息香酸エチル、と異なり、化粧水にも
容易に溶解する。これらの化粧料の処方は公知の化粧料
の処方に準じ、これにチアミン類が化粧料全体の0.1
重量%以上、好ましくは0.1〜0.2重量%の割合で
含有される。過少であると後述のチアミン類の効果が得
られず。Since thiamines are water-soluble, unlike conventional ultraviolet absorbers 1 such as ethyl para-aminobenzoate, they easily dissolve in lotions. The formulations of these cosmetics are based on the formulations of known cosmetics, and thiamin is added to the total amount of 0.1% of the cosmetics.
It is contained in a proportion of at least 0.1% by weight, preferably 0.1 to 0.2% by weight. If the amount is too low, the effects of thiamin described below will not be obtained.
過剰であっても含有量に比例した効果は得られない。本
発明の化粧料の製造方法も通常の場合に準じる。例えば
クリームであれば、ステアリン酸。Even if it is in excess, an effect proportional to the content cannot be obtained. The method for producing the cosmetic of the present invention also follows the usual method. For example, if it's a cream, it's stearic acid.
ステアリルアルコール、還元ラノリン、スクワレンなど
の油性成分;オクチルドデカノール、ポリオキシエチレ
ンセチルエーテル、モノステアリン酸グリセリンなどの
乳化剤;水、プロピレングリコールなどの水性成分;香
料;酸化防止剤などの通常のクリーム原料およびチアミ
ンを通常の混練機を用いて均一に混練して得られる。Oil-based ingredients such as stearyl alcohol, reduced lanolin, and squalene; Emulsifiers such as octyldodecanol, polyoxyethylene cetyl ether, and glycerin monostearate; Water-based ingredients such as water and propylene glycol; Fragrance; Regular cream ingredients such as antioxidants and thiamine are uniformly kneaded using a conventional kneader.
本発明の化粧料に含有されるチアミン類1例えばチアミ
ンは1図に示すように、200〜300nmに吸収を有
する(図はO,1mMのチアミンを含有する20mMリ
ン酸ナトリウム水溶液(pH7,4)のυVチャートで
ある)。そのため1本発明の化粧料を皮膚に塗布すると
主としてA領域紫外線を効果的に吸収し、皮膚に紅斑や
痛みを伴う急性の炎症を生じさせない。チアミン類は、
また、 300nm以上の紫外線を吸収しないため、近
紫外線は吸収されずに皮膚に到達してメラニン色素の沈
着を引き起こす。このとき、「従来の技術」の項で述べ
たような近紫外線照射により生じる励起酸素を含む化合
物やニトロソアミン類からの反応中間体が生じるが2本
発明化粧料に含有されるチアミン類がこれらを捕捉する
能力を有する。そのため、近紫外線が皮膚に到達するに
もかかわらず、皮膚細胞のDNAが損傷・変性を受けな
い。従って、チアミン類を配合した本発明の化粧料を皮
膚に塗布すると皮百の老化や皮膚癌の発生を抑制するこ
とができる。Thiamines contained in the cosmetics of the present invention 1 For example, thiamine has an absorption in the range of 200 to 300 nm as shown in Figure 1 (the figure shows O, a 20mM aqueous sodium phosphate solution containing 1mM thiamine (pH 7.4)). ). Therefore, when the cosmetic of the present invention is applied to the skin, it effectively absorbs mainly A-region ultraviolet rays and does not cause erythema or painful acute inflammation on the skin. Thiamines are
Furthermore, since it does not absorb ultraviolet rays of 300 nm or more, near ultraviolet rays reach the skin without being absorbed and cause melanin pigment deposition. At this time, reaction intermediates from compounds containing excited oxygen and nitrosamines are generated due to near ultraviolet irradiation as described in the "Prior Art" section, but the thiamines contained in the cosmetics of the present invention do not react with these compounds. Has the ability to capture. Therefore, even though near ultraviolet rays reach the skin, the DNA of skin cells is not damaged or denatured. Therefore, when the cosmetic of the present invention containing thiamines is applied to the skin, skin aging and the occurrence of skin cancer can be suppressed.
チアミン類は近紫外線を透過しうるため日焼は用化粧品
に応用され得、さらに近紫外線をも遮断しうる紫外線吸
収剤やカオリン、タルクなどを配合すれば2日焼は止め
用化粧品にも応用が可能である。本発明化粧料に用いら
れるチアミンは必須ビタミンの1種であるビタミンB1
であり、チアミンピロリン酸やチアミンモノリン酸はチ
アミンが人体に摂取されて代謝された結果、生じる生体
生成物である。このように本発明に使用されるチアミン
類は人体にとって無害であり、かつ有益な成分である。Since thiamin can transmit near-ultraviolet rays, it can be applied to sun-tanning cosmetics, and if UV absorbers, kaolin, talc, etc., which can also block near-ultraviolet rays are added, it can also be applied to sun-tanning cosmetics. is possible. Thiamine used in the cosmetics of the present invention is vitamin B1, which is a type of essential vitamin.
Thiamine pyrophosphate and thiamine monophosphate are biological products produced as a result of thiamine being ingested and metabolized by the human body. As described above, the thiamines used in the present invention are harmless and beneficial components for the human body.
そのため本発明の化粧料の安全性は極めて高い。Therefore, the safety of the cosmetic of the present invention is extremely high.
(実施例) 以下に本発明を実施例につき説明する。(Example) The invention will be explained below with reference to examples.
尖施±上 ファージφ×174から常法によりDNAを抽出した。tip top DNA was extracted from phage φ×174 by a conventional method.
このDNAは二本鎖の超らせん環状構造をしたRFI型
DNAである。RFI型DNAの一本鎖切断が生じると
リラックス環状型のDNA (RF II型DNA)と
なることが知られている。このRFI型DNA 0.2
μgを含有する0、1M リン酸ナトリウム緩衝液15
μlに。This DNA is an RFI type DNA having a double-stranded superhelical circular structure. It is known that when a single strand break occurs in RFI type DNA, it becomes relaxed circular type DNA (RF type II DNA). This RFI type DNA 0.2
0.1 M sodium phosphate buffer containing 15 μg
in μl.
Q終濃度が0.81となるように4−チオデオキシウリ
ジン溶液を加えた。別に表1に示す処方で常法によりク
リーム(エモリエントクリーム)を調製し、その10+
ngを上記4−チオデオキシウリジンを含む緩衝液に加
えて混合した。これを3mm厚の透明ガラス板でおおい
、ガラス板上から東芝ブラックライトFL2’0BLB
(20W) 2本により常温で1時間紫外線照射を行
った。DNA、4−チオデオキシウリジンおよびクリー
ムを含む反応液表面(直径7、−の円形)での紫外線強
度は3.5μ−7mm”であった。A 4-thiodeoxyuridine solution was added so that the final Q concentration was 0.81. Separately, a cream (emollient cream) was prepared by a conventional method using the formulation shown in Table 1, and its 10+
ng was added to the buffer solution containing 4-thiodeoxyuridine and mixed. This was covered with a 3mm thick transparent glass plate, and the Toshiba Blacklight FL2'0BLB was placed on top of the glass plate.
(20W) Ultraviolet irradiation was performed for 1 hour at room temperature using two tubes. The intensity of ultraviolet rays on the surface of the reaction solution (diameter 7, - circle) containing DNA, 4-thiodeoxyuridine, and cream was 3.5 μ-7 mm.
紫外線照射後の反応液をアガロースゲル電気泳動にかけ
、エチジウム染色を行い、その螢光強度をデンシトメー
ターで測定しI?FI型DNAとRFIT型DNAとを
それぞれ定量した。その結果を表6に示す。実施例2〜
5および比較例1〜5の結果もあわせて表6に示す。表
6において阻害率とはIIFI型DNAがI?FII型
ON八となるへを阻害する度合をいう。阻害率は、紫外
線照射を全く行わない場合の1?Fn型DNAの生成率
(14%)を100%とし、チアミンを含まないクリー
ムを用いた場合のIIFn型DNAの生成率(64%;
比較例1)を0%として算出した。The reaction solution after UV irradiation was subjected to agarose gel electrophoresis, ethidium staining was performed, and the fluorescence intensity was measured with a densitometer. FI type DNA and RFIT type DNA were each quantified. The results are shown in Table 6. Example 2~
5 and Comparative Examples 1 to 5 are also shown in Table 6. In Table 6, the inhibition rate means that IIFI type DNA is I? It refers to the degree to which it inhibits the development of FII type ON8. Is the inhibition rate 1 when no UV irradiation is performed? The production rate of IIFn type DNA (64%) when using a cream that does not contain thiamine, assuming the production rate of Fn type DNA (14%) as 100%.
Calculations were made assuming Comparative Example 1) as 0%.
表1 クリームの処方 次11九l 常法により表2に示す処方の乳液を調製した。Table 1 Cream prescription Next 119l A milky lotion having the formulation shown in Table 2 was prepared by a conventional method.
クリームの代わりにこの乳液10■を用い、実施例1に
準じて実験を行った。ただし、4−チオデオキシウリジ
ン(0,8mM)の代わりにジエチルニトロソアミン(
1mM>を使用した。An experiment was conducted according to Example 1 using 10 ml of this emulsion instead of the cream. However, instead of 4-thiodeoxyuridine (0.8mM), diethylnitrosamine (
1mM> was used.
表2 乳液の処方
災旌斑主
常法により表3に示す処方のパウダーファンデーション
を調製した。クリームの代わりにこのパウダーファンデ
ーション10■を用い、実施例1に準じて実験を行った
。その結果を表6に示す。Table 2: Prescription of Emulsion Powder foundations having the formulations shown in Table 3 were prepared using a conventional method. An experiment was conducted according to Example 1 using 10 ml of this powder foundation instead of the cream. The results are shown in Table 6.
表3 パウダーファンデーションの処方常法により表4
に示す処方の口紅を調製した。Table 3 Table 4 according to the conventional formula for powder foundation
A lipstick with the formulation shown in was prepared.
クリームの代わりにこの口紅10■を用い、実施例1に
準じて実験を行った。 。An experiment was conducted according to Example 1 using 10 ml of this lipstick instead of the cream. .
表4 口紅の処方 常法により表5に示す処方の化粧水を調製した。Table 4 Lipstick prescription A lotion having the formulation shown in Table 5 was prepared by a conventional method.
クリームの代わりにこの化粧水10wを用い、実施例1
に準じて実験を行った。Example 1 Using 10w of this lotion instead of cream
The experiment was conducted according to.
(以下余白)
表5 化粧水の処方
表1の処方からチアミンを除き、チアミンに相当する量
の精製水を加えてクリームを調製した。(The following is a blank space) Table 5 Formula of lotion A cream was prepared by removing thiamin from the formulation in Table 1 and adding an amount of purified water corresponding to thiamin.
これを用い、実施例1に準じて実験を行った。その結果
を表6に示す。Using this, an experiment was conducted according to Example 1. The results are shown in Table 6.
工較燃1
表2の処方からチアミンモノリン酸エステルを除き、チ
アミンモノリン酸エステルに相当する量の精製水を加え
て乳液を調製した。これを用い。Calibration 1 A milky lotion was prepared by removing thiamine monophosphate from the formulation in Table 2 and adding purified water in an amount corresponding to the amount of thiamine monophosphate. Use this.
実施例1に準じて実験を行った。その結果を表6に示す
。An experiment was conducted according to Example 1. The results are shown in Table 6.
ル笠炎主
表3の処方からチアミンを除き、チアミンに相当する量
のタルクを加えてパウダーファンデーションを調製した
。これを用い、実施例1に準じて実験を行った。その結
果を表6に示す。A powder foundation was prepared by removing thiamin from the formulation in Table 3 and adding talc in an amount equivalent to thiamin. Using this, an experiment was conducted according to Example 1. The results are shown in Table 6.
ル較斑↓
表4の処方からチアミンピロリン酸エステルを除き、チ
アミンピロリン酸エステルに相当する世のヒマシ油を加
えて口紅を調製した。これを用い。A lipstick was prepared by removing thiamine pyrophosphate from the formulation in Table 4 and adding castor oil, which corresponds to thiamine pyrophosphate. Use this.
実施例1に準じて実験を行った。その結果を表6に示す
。An experiment was conducted according to Example 1. The results are shown in Table 6.
里紋五i
表5の処方からチアミンを除き、チアミンに相当する量
の精製水を加えて化粧水を調製した。これを用い、実施
例1に準じて実験を行った。その結果を表6に示す。Satomongoi A lotion was prepared by removing thiamin from the formulation in Table 5 and adding purified water in an amount equivalent to thiamin. Using this, an experiment was conducted according to Example 1. The results are shown in Table 6.
(以下余白)
(発明の効果)
本発明によれば、このように、紫外線、特に近紫外線、
による皮膚細胞のDNA tU傷を抑制しうる化粧料が
得られる。このような化粧料を用いると。(The following is a blank space) (Effects of the invention) According to the present invention, ultraviolet rays, especially near ultraviolet rays,
A cosmetic material capable of suppressing DNA tU damage to skin cells caused by this method can be obtained. When using such cosmetics.
太陽光によるしみ、しわ、さらには皮膚癌の発生が抑制
される。化粧料自体の安全性も高い。この化粧料はA領
域紫外線を吸収し、かつ近紫外線をよ(透過するため日
焼は用化粧品に好適に利用され得、「美しい小麦色の肌
」をつくり、かつ1 しみやしわを残さないという利点
を有する。この化粧料にA領域紫外線を吸収しうる紫外
線吸収剤を配合すれば日焼は止め化粧品としても有用で
ある。The development of sun spots, wrinkles, and even skin cancer is suppressed. The cosmetics themselves are also highly safe. Since this cosmetic absorbs A-region ultraviolet rays and transmits near-ultraviolet rays, it can be suitably used in sun-baked cosmetics, creating ``beautiful tan-colored skin,'' and 1. It does not leave spots or wrinkles. If a UV absorber capable of absorbing A-region ultraviolet rays is added to this cosmetic, it can also be useful as a sunscreen cosmetic.
図はチアミンのUv吸収を示すチャートである。The figure is a chart showing the UV absorption of thiamine.
以上that's all
Claims (1)
る化粧料。 2、前記チアミンエステルがチアミンピロリン酸エステ
ルおよび/またはチアミンモノリン酸エステルである特
許請求の範囲第1項に記載の化粧料。[Claims] 1. A cosmetic containing thiamine and/or thiamine ester. 2. The cosmetic according to claim 1, wherein the thiamine ester is a thiamine pyrophosphate ester and/or a thiamine monophosphate ester.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10284286A JPS62258313A (en) | 1986-05-02 | 1986-05-02 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10284286A JPS62258313A (en) | 1986-05-02 | 1986-05-02 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62258313A true JPS62258313A (en) | 1987-11-10 |
Family
ID=14338222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10284286A Pending JPS62258313A (en) | 1986-05-02 | 1986-05-02 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62258313A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006122685A1 (en) * | 2005-05-17 | 2006-11-23 | Greenleaf Srl | Compositions for the treatment of psoriasis |
-
1986
- 1986-05-02 JP JP10284286A patent/JPS62258313A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006122685A1 (en) * | 2005-05-17 | 2006-11-23 | Greenleaf Srl | Compositions for the treatment of psoriasis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2907495C (en) | Antioxidant compositions and methods of using the same | |
JP2000095663A (en) | Agent for external use containing plant extract | |
JPH0466844B2 (en) | ||
JP4070935B2 (en) | Acne skin external preparation | |
EP2809295B1 (en) | Composition and association of sunscreens for photostabilizing butyl methoxydibenzoylmethane (bmdbm) | |
US20050226825A1 (en) | Topical composition for preventing and treating skin damage caused by UV light exposure | |
EP1216019A1 (en) | No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product | |
JPWO2006115190A1 (en) | Skin cosmetics and wrinkle improvers | |
JPH08119849A (en) | Skin preparation for external use | |
JP4934280B2 (en) | Wrinkle improving agent | |
JP4579564B2 (en) | Wrinkle improving agent | |
JP2006022090A (en) | Inflammation inhibitor composed of pyrrolidonecarboxylic acid zinc salt | |
DE60120142T2 (en) | USE OF ALCOHOL DEHYDROGENASE INHIBITORS IN THE COSMETIC TREATMENT OF KERATIN SUBSTANCES | |
JP2552298B2 (en) | Beautiful skin cosmetics | |
JPS62258313A (en) | Cosmetic | |
EP3643293A1 (en) | An olive oil-based concentrate and a topically applied preparation for skin care and repair comprising said concentrate | |
JPH072640A (en) | External preparation for protecting ultraviolet disorder | |
JPH0692833A (en) | Skin external agent | |
JP2004026817A (en) | Skin care preparation for bleaching | |
KR100428817B1 (en) | Cosmetic composition having UV-blocking and slimming effects | |
JP4488933B2 (en) | Wrinkle improving agent and external composition for skin | |
JPS62120312A (en) | Skin beautifying cosmetic | |
KR102419399B1 (en) | Cica-care cream composition and manufacturing method thereof | |
WO2021060185A1 (en) | Near-infrared screening agent and near-infrared screening external preparation for skin | |
JP3826132B2 (en) | Wrinkle improving agent |